Physician profile
Barry B Abraham
NPI 1811072606
$2,867.07
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $481 · 2021: $1,325 · 2022: $160.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,250.17 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $339.00 | 2019-2022 | |
| Abbvie INC. | $282.76 | 2019-2022 | |
| Genzyme Corporation | $122.35 | 2019-2021 | |
| Helsinn Therapeutics (U.S.), INC. | $104.04 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $96.22 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $96.20 | 2019-2021 | |
| Genentech USA, INC. | $86.35 | 2019-2021 | |
| Lilly USA, LLC | $74.31 | 2019-2022 | |
| Pfizer INC. | $66.09 | 2019-2021 | |
| Ucb, INC. | $59.37 | 2020-2021 | |
| Prugen, INC. Pharmaceuticals | $54.42 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.55 | 2019-2021 | |
| Leo Pharma INC. | $36.92 | 2021-2022 | |
| Dusa Pharmaceuticals, INC. | $25.08 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $23.40 | 2019 | |
| Amgen INC. | $22.21 | 2021 | |
| Strata Skin Sciences, INC. | $20.98 | 2021 | |
| Epi Health, LLC | $20.20 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.47 | 2021 | |
| Merck Sharp & Dohme LLC | $13.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.